REQUEST A DEMO
Total
USD $0.00
Search more companies

Imuna Pharm, A.S. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Imuna Pharm, A.S. Profile Updated: October 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

IMUNA PHARM, a. s., a.s. is a Slovak pharmaceutical company that specializes in pharmaceutical production, including infused solutions and blood derivatives. It focuses on meeting technical requirements and criteria set by the World Health Organization and EU legislation. IMUNA PHARM, a. s. has modernized its production capacities, expanded into foreign markets, and is the exclusive processor of Czech and Slovak plasma for blood derivatives. The company also has a production program for dietary preparations. IMUNA PHARM, a. s. generates revenue through its pharmaceutical products and solutions.

Headquarters
Jarkova, 269/17
Sarisske Michalany; Postal Code: 08222

Contact Details: Purchase the Imuna Pharm, A.S. report to view the information.

Website: http://www.imuna.sk

Basic Information
Total Employees:
Purchase the Imuna Pharm, A.S. report to view the information.
Outstanding Shares:
Purchase the Imuna Pharm, A.S. report to view the information.
Registered Capital:
Purchase the Imuna Pharm, A.S. report to view the information.
Incorporation Date:
June 26, 2001
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Imuna Pharm, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-51.27%
Total operating revenue
-25.77%
Operating profit (EBIT)
-69.74%
EBITDA
N/A
Net Profit (Loss) for the Period
-56.91%
Total assets
-8.78%
Total equity
-47.84%
Operating Profit Margin (ROS)
-30.87%
Net Profit Margin
-31.15%
Return on Equity (ROE)
-59.08%
Debt to Equity Ratio
96.54%
Quick Ratio
0%
Cash Ratio
-0%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?